AVTX Archived Articles

Avalo Therapeutics (NASDAQ:AVTX): Advancing its Anti-IL-1β Candidate in Hidradenitis Suppurativa


Avalo Therapeutics (AVTX): Unlocking the Potential of Immune Dysregulation


Avalo Therapeutics, Inc. (NASDAQ:AVTX): Transforming Immune Dysregulation with a Promising Pipeline